drugset / Trial / NCT03701581
4-aminopyridine Treatment for Nerve Injury
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury. This study aims to test the hypothesis that 4-aminopyridine speeds the often slow and unpredictable recovery after peripheral nerve traction and/or crush injuries.
Timeline
- Start
- 2021-06-05
- Primary completion
- 2027-07
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalfampridine | Small molecule | 10 mg | Oral |